Visicol and Weight increased - a phase IV clinical study of FDA data

Summary:

Weight increased is reported as a side effect among people who take Visicol (sodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Geodon, and have Bipolar disorder.

The phase IV clinical study analyzes which people have Weight increased when taking Visicol. It is created by eHealthMe based on reports of 470 people who have side effects when taking Visicol from the FDA, and is updated regularly.

What is Visicol?

Visicol has active ingredients of sodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate. eHealthMe is studying from 471 Visicol users. Check the latest studies of Visicol.

What is Weight increased?

Weight increased is found to be associated with 2,886 drugs and 3,952 conditions by eHealthMe. Check the latest studies of Weight increased.

On Jul, 14, 2026

470 people reported to have side effects when taking Visicol.
Among them, 19 people (4.04%) have Weight increased.

Among these 19 people:

How long have people been on Visicol when they have Weight increased? *

What is the gender of people who have Weight increased when taking Visicol? *

female: 36.84 %
male: 63.16 %

What is the age of people who have Weight increased when taking Visicol? *

What are other drugs people take besides Visicol? *

What are other side effects people have besides Weight increased? *

Acute Kidney Failure: 8 people, 42.11%
Type 2 Diabetes: 5 people, 26.32%
Neuropathy Peripheral (surface nerve damage): 5 people, 26.32%
Gastritis (inflammation of stomach): 4 people, 21.05%
Labyrinthitis (inflammation of the labyrinth or inner ear): 4 people, 21.05%
Nephrocalcinosis (a condition in which calcium levels in the kidneys are increased): 4 people, 21.05%
Rotator Cuff Syndrome (a spectrum of conditions affecting the rotator cuff tendons of the shoulder): 4 people, 21.05%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 4 people, 21.05%
Metabolic Acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body): 3 people, 15.79%
Generalised Oedema (swelling all over the body): 3 people, 15.79%

What are the existing conditions these people have? *

High Blood Cholesterol: 5 people, 26.32%
Bipolar Disorder (mood disorder): 5 people, 26.32%
High Blood Pressure: 3 people, 15.79%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 10.53%
Inflammation: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Visicol and have Weight increased?

- Check whether Weight increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Visicol:

Visicol (471 reports)

Weight increased treatments and more:

Weight increased (279,369 reports)

How severe was Weight increased and when was it recovered:

Weight increased in Visicol

Expand to all the drugs that have ingredients of sodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate:

Weight increased and drugs with ingredients of sodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate (42 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Visicol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weight increased:

Weight increased (2,886 drugs)

Browse all the conditions that are associated with Weight increased:

Weight increased (3,952 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate (the active ingredients of Visicol) and Visicol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.